NeuroPace, Inc.
NASDAQ: NPCE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Joel D. Becker
- Employees
- 203
- Headquarters
- Mountain View, United States
- IPO year
- 2021
- Market cap
- $553.0M
- Website
- https://www.neuropace.com
Loading NPCE…
Loading profile data…Frequently asked questions about NPCE
What does NeuroPace, Inc. (NPCE) do?
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Pa...
Where does NPCE trade?
NeuroPace, Inc. (NPCE) trades on the NASDAQ.
What sector is NPCE in?
NeuroPace, Inc. (NPCE) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of NeuroPace, Inc.?
Joel D. Becker is the chief executive officer of NeuroPace, Inc. (NPCE).
Where is NeuroPace, Inc. headquartered?
NeuroPace, Inc. is headquartered in United States.
Does NPCE pay a dividend?
NeuroPace, Inc. (NPCE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NPCE go public?
NeuroPace, Inc. (NPCE) completed its initial public offering in 2021.